Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 4/20 | 0.53 |
| ▸ | MGAM | O43451 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | SI | P14410 | 2/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.44 |
| ▸ | PPARG | P37231 | 2/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.43 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.38 |
| ▸ | APP | P05067 | 2/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | PTGES | O14684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7095342 | 1.00 | BACE1 (0.53) | BACE1MGAMGAASIMGAM2 | |
| SCHEMBL12281887 | 0.88 | BACE1 (0.55) | BACE1MGAMGAASIMGAM2 | |
| SCHEMBL5363034 | 0.82 | BACE1 (0.74) | BACE1ALOX5PPARGNR1I2PPARA | |
| SCHEMBL15970248 | 0.75 | ALOX15 (0.54) | BACE1MGAMGAASIMGAM2 | |
| SCHEMBL14248208 | 0.75 | ALOX15 (0.54) | BACE1MGAMGAASIMGAM2 | |
| SCHEMBL3822074 | 0.75 | BACE1 (0.64) | BACE1NR1H4APPMAOB | |
| SCHEMBL3822078 | 0.75 | BACE1 (0.64) | BACE1NR1H4APPMAOB | |
| SCHEMBL15970369 | 0.74 | MGAM (0.56) | BACE1MGAMGAASIMGAM2 | |
| SCHEMBL15970293 | 0.74 | ALOX15 (0.53) | BACE1MGAMGAASIMGAM2 | |
| SCHEMBL15970370 | 0.74 | MGAM (0.56) | BACE1MGAMGAASIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030206936-A1 | Cosmetic composition and method of treating skin and hair | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030206936-A1 | Cosmetic composition and method of treating skin and hair | HSD3B1, EBP, CYP8B1 | BACE1 1422/4885MGAM 4696/4885GAA 3367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.